|
 | Up a level |
Sehgal, M and Ramu, S and Vaz, JM and Ganapathy, YR and Muralidharan, S and Venkatraghavan, S and Jolly, MK (2024) Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends. In: Translational Oncology, 40 .
Pillai, M and Rajaram, G and Thakur, P and Agarwal, N and Muralidharan, S and Ray, A and Barbhaya, D and Somarelli, JA and Jolly, MK (2022) Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis. In: Frontiers in Oncology, 12 .
Muralidharan, S and Sahoo, S and Saha, A and Chandran, S and Majumdar, SS and Mandal, S and Levine, H and Jolly, MK (2022) Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial–Hybrid–Mesenchymal Spectrum in Cancer. In: Biomolecules, 12 (2).
Sahoo, S and Mishra, A and Kaur, H and Hari, K and Muralidharan, S and Mandal, S and Jolly, MK (2021) A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells. In: NAR Cancer, 3 (3).
